Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain

por Stroet, Marcus C. M., de Blois, Erik, de Jong, Marion, Seimbille, Yann, Mezzanotte, Laura, Löwik, Clemens W. G. M., Panth, Kranthi M.
Publicado 2022

In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors

por Stroet, Marcus C. M., de Blois, Erik, Haeck, Joost, Seimbille, Yann, Mezzanotte, Laura, de Jong, Marion, Löwik, Clemens W. G. M., Panth, Kranthi M.
Publicado 2021

In Vivo Evaluation of Indium-111–Labeled 800CW as a Necrosis-Avid Contrast Agent

por Stroet, Marcus C. M., de Blois, Erik, Stuurman, Debra C., de Ridder, Corrina M. A., Haeck, Joost, Seimbille, Yann, Mezzanotte, Laura, de Jong, Marion, Löwik, Clemens W. G. M., Panth, Kranthi M.
Publicado 2020

Necrosis binding of Ac-Lys(0)(IRDye800CW)-Tyr(3)-octreotate: a consequence from cyanine-labeling of small molecules

por Stroet, Marcus C. M., Dijkstra, Bianca M., Dulfer, Sebastiaan E., Kruijff, Schelto, den Dunnen, Wilfred F. A., Kruyt, Frank A. E., Groen, Rob J. M., Seimbille, Yann, Panth, Kranthi M., Mezzanotte, Laura, Lowik, Clemens W. G. M., de Jong, Marion
Publicado 2021

A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal ad...

por Larue, Ruben T. H. M., Van De Voorde, Lien, Berbée, Maaike, van Elmpt, Wouter J. C., Dubois, Ludwig J., Panth, Kranthi M., Peeters, Sarah G. J. A., Claessens, Ann, Schreurs, Wendy M. J., Nap, Marius, Warmerdam, Fabiënne A. R. M., Erdkamp, Frans L. G., Sosef, Meindert N., Lambin, Philippe
Publicado 2016